{{Rsnum
|rsid=1535435
|Gene=AHI1
|Chromosome=6
|position=135435884
|Orientation=plus
|GMAF=0.2098
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=AHI1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 13.3 | 85.8
| HCB | 0.7 | 13.1 | 86.1
| JPT | 0.0 | 11.5 | 88.5
| YRI | 45.9 | 41.8 | 12.3
| ASW | 38.6 | 38.6 | 22.8
| CHB | 0.7 | 13.1 | 86.1
| CHD | 0.9 | 13.8 | 85.3
| GIH | 0.0 | 23.8 | 76.2
| LWK | 53.2 | 35.8 | 11.0
| MEX | 0.0 | 22.4 | 77.6
| MKK | 45.5 | 44.9 | 9.6
| TSI | 1.0 | 6.9 | 92.2
| HapMapRevision=28
}}

Originally reported to be associated with [[type-2 diabetes]] in a genome-wide association study; yet then reported not to be associated with either T2D or related metabolic traits in a large Danish population (ultimately 17,000 patients for the latter study).{{PMID|18227995}}

{{PMID|17668382|OA=1
}} Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}